Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Cox

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|April 3, 2025
Dancing with the cells: How acoustically levitating a diamond enabled a redesign of biotech automationLuke Cox
Harm Reduction Journal|November 11, 2025
Bigger than sport: the enhanced games and the commodification of telehealth, testosterone, and dependencyLuke Cox, Imran Khan
Harm Reduction Journal|July 27, 2025
"Injecting yourself there is stigma around it; taking a few tablets is not too bad, is it?": understanding perceptions and preferences of anabolic-androgenic steroid route of administrationLuke Cox, Timothy Piatkowski, Matthew Dunn
Health Sociology Review : the Journal of the Health Section of the Australian Sociological Association|August 11, 2024
The ethics of enhancement among image and performance enhancing drug coachesTimothy Piatkowski, Luke Cox, Rick Collins
Scientific Reports|August 25, 2022
Dynamic patterning of microparticles with acoustic impulse controlLuke Cox, Anthony Croxford, Bruce W Drinkwater
The International Journal on Drug Policy|November 11, 2023
Big business: The private sector market for image and performance enhancing drug harm reduction in the UKLuke Turnock, Nick Gibbs, Luke Cox, et al.
Health (London, England : 1997)|November 8, 2025
Making 'safer injecting' matter for people who inject image and performance enhancing drugsTimothy Piatkowski, Emma Kill, Sonya Weith, et al.
Current Oncology Reports|January 18, 2024
PARP Inhibitors in Breast Cancer: a Short CommunicationGordon R Daly, Maen Monketh AlRawashdeh, Jason McGrath, et al.
Frontiers in Oncology|May 21, 2024
A bibliometric analysis of HER2-positive breast cancer: 1987-2024Sherlissa Ali-Thompson, Gordon R Daly, Gavin P Dowling, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|April 3, 2025
Dancing with the cells: How acoustically levitating a diamond enabled a redesign of biotech automationLuke Cox
Harm Reduction Journal|November 11, 2025
Bigger than sport: the enhanced games and the commodification of telehealth, testosterone, and dependencyLuke Cox, Imran Khan
Harm Reduction Journal|July 27, 2025
"Injecting yourself there is stigma around it; taking a few tablets is not too bad, is it?": understanding perceptions and preferences of anabolic-androgenic steroid route of administrationLuke Cox, Timothy Piatkowski, Matthew Dunn
Health Sociology Review : the Journal of the Health Section of the Australian Sociological Association|August 11, 2024
The ethics of enhancement among image and performance enhancing drug coachesTimothy Piatkowski, Luke Cox, Rick Collins
Scientific Reports|August 25, 2022
Dynamic patterning of microparticles with acoustic impulse controlLuke Cox, Anthony Croxford, Bruce W Drinkwater
The International Journal on Drug Policy|November 11, 2023
Big business: The private sector market for image and performance enhancing drug harm reduction in the UKLuke Turnock, Nick Gibbs, Luke Cox, et al.
Health (London, England : 1997)|November 8, 2025
Making 'safer injecting' matter for people who inject image and performance enhancing drugsTimothy Piatkowski, Emma Kill, Sonya Weith, et al.
Current Oncology Reports|January 18, 2024
PARP Inhibitors in Breast Cancer: a Short CommunicationGordon R Daly, Maen Monketh AlRawashdeh, Jason McGrath, et al.
Frontiers in Oncology|May 21, 2024
A bibliometric analysis of HER2-positive breast cancer: 1987-2024Sherlissa Ali-Thompson, Gordon R Daly, Gavin P Dowling, et al.
Pageof 1